GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Pre-Tax Income

ZYUS Life Sciences (TSXV:ZYUS) Pre-Tax Income : C$-49.84 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. ZYUS Life Sciences's pretax income for the three months ended in Mar. 2024 was C$-3.36 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was C$-49.84 Mil. ZYUS Life Sciences's pretax margin was -2,942.98%.

During the past 3 years, ZYUS Life Sciences's highest Pretax Margin was -8293.62%. The lowest was -13800.28%. And the median was -11387.44%.


ZYUS Life Sciences Pre-Tax Income Historical Data

The historical data trend for ZYUS Life Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Pre-Tax Income Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-23.57 -24.72 -48.44

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.85 -12.00 -4.21 -30.28 -3.36

Competitive Comparison of ZYUS Life Sciences's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Pre-Tax Income falls into.



ZYUS Life Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

ZYUS Life Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-17.192+-27.402+-3.272+0+-0.573
=-48.44

ZYUS Life Sciences's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.185+0.075+-0.185+0+-0.06
=-3.36

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-49.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZYUS Life Sciences  (TSXV:ZYUS) Pre-Tax Income Explanation

ZYUS Life Sciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.355/0.114
=-2,942.98%

During the past 3 years, ZYUS Life Sciences's highest Pretax Margin was -8293.62%. The lowest was -13800.28%. And the median was -11387.44%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZYUS Life Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines